The year 2011 was a year of capturing potential markets and achieving new milestones. Ranbaxy Laboratories became the fi...
Singapore: Patrys received approval to progress its phase I/IIa PAT-SM6 multiple myeloma trial based on safety data from...
Singapore: TB Alliance has started a clinical trial of a new regimen to treat extensively drug-resistant tuberculosis (X...
Singapore: US based oncology biotechnology company, Ignyta, has acquired four targeted oncology development programs fro...
Singapore: MMRGlobal received confirmation of the filings of a divisional application for its antibody technology in Jap...
Singapore: In a bid to further foster new drug research for drug resistant tuberculosis (TB), Wellcome Trust has collabo...
Singapore: Johnson & Johnson plans to establish four regional innovation centers in major life sciences communities ...
Singapore: Amgen has received positive results from its global Phase 2 clinical trial of AMG 334, a fully human monoclon...
Singapore: OccuRx, an Australian biopharmaceutical company developing a new class of drugs to prevent health burden due ...
Singapore: US-based Nektar Therapeutics has revealed positive preclinical data for NKTR-214, a novel cancer immunotherap...
Singapore: A group of international researchers, including from University of Melbourne, have discovered a new class of ...
Singapore: India-based Suven Lifescinces has secured patents for its new chemical entities (NCEs) from Japan, China, New...
Singapore: Israel-based D-Pharm has recieved new patent in the US and China, related to composition and use of THR-18, a...
Singapore: Australia based Novogen's lead candidate, TRXE-009, developed for the treatment of brain cancers, has shown t...
Singapore: A team of scientists from Cancer Science Institute of Singapore (CSI Singapore) at the National University of...
Singapore: Certara, a drug development and drug safety consultancy firm has launched its D360 software in Japan for prov...
Singapore: Chinese biotechnology firm, 3SBio, has signed an exclusive license with Korean firm, DiNonA for the develop...
Singapore: Australia-based clinical-stage drug development company, Invion, initiated and commenced patient enrolment in...
